ArticleBMC cancer2022
Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4.
Shuai Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleBMC cancer2022
Shuai Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.